Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.36 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | CDC25A | P30304 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17418199 | 1.00 | KDM4E (0.45) | KDM4ELMNAKMT2ABBOX1APOBEC3A | |
| SCHEMBL17418238 | 1.00 | KDM4E (0.45) | KDM4ELMNAKMT2ABBOX1APOBEC3A | |
| SCHEMBL17418465 | 0.99 | KDM4E (0.47) | KDM4ELMNAKMT2ABBOX1APOBEC3A | |
| SCHEMBL17418684 | 0.99 | KDM4E (0.47) | KDM4ELMNAKMT2ABBOX1APOBEC3A | |
| SCHEMBL17418980 | 0.99 | KDM4E (0.47) | KDM4ELMNAKMT2ABBOX1APOBEC3A | |
| SCHEMBL17418432 | 0.96 | KDM4E (0.50) | KDM4ELMNAKMT2ABBOX1APOBEC3A | |
| SCHEMBL17418391 | 0.95 | KDM4E (0.53) | KDM4ELMNAKMT2ABBOX1APOBEC3A | |
| SCHEMBL17418526 | 0.94 | BBOX1 (0.40) | KDM4ELMNAKMT2ABBOX1APOBEC3A | |
| SCHEMBL17418816 | 0.93 | KDM4E (0.41) | KDM4ELMNAKMT2ABBOX1APOBEC3A | |
| SCHEMBL17418397 | 0.92 | KDM4E (0.54) | KDM4ELMNAKMT2ABBOX1APOBEC3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10087155-B2 | Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2018-10-02 | — | — | US | disclosed |
| US-20160009669-A1 | ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160009669-A1 | ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD | CEL, CROCC, ALG1 | KDM4E 1130/4885LMNA 271/4885KMT2A 2922/4885 |
| US-10087155-B2 | Onium salt, liquid composition containing said onium salt and cellulose, and cellulose recovery method | CEL, CROCC, ALG1 | KDM4E 1130/4885LMNA 271/4885KMT2A 2922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.